News

It also entered into a settlement and license agreement with AstraZeneca, pursuant to which AstraZeneca granted a license to Teva to manufacture and commercialize the generic version of

Napabucasin is an orally administered cancer stemness inhibitor designed to inhibit cancer stemness pathways by targeting STAT3, and is currently being investigated in a global Phase III clinical

GVHD is a condition where the donated bone marrow or peripheral blood stem cells see the recipient’s body as foreign and attack the body. It is a significant

The US authorities have recommended against its use saying that the vaccine showed ‘poor or relatively lower effectiveness’ of LAIV from 2013 through 2016. CDS said in a

The House voted 239-171 to pass the bill. The deal matches the $1.1bn figure adopted by the Senate last month to combat the virus. Republican House Speaker Paul

This antibody candidate is now undergoing preclinical development activities in preparation for advancement to clinical trials, with an anticipated IND filing next year. CGEN-15029 is one of multiple

The RAC also issued recommendations on several design elements of the research and clinical development program. DTX301 is an adeno-associated virus (AAV) gene therapy product being developed to

The objective of this pharmacokinetic proof of concept study was to assess two prospective formulations of Hydrocodone DETERx in a bioavailability clinical study. The primary goals were to

It gives Anavex a seven year window of commercial exclusivity in the US in the area of infantile spasms, prioritized consultation by the FDA on clinical studies and